Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery

Hun Lee, Sang Myung Kim, Seonghee Choi, KyoungYul Seo, Eungkweon Kim, Tae-im Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The aim was to evaluate the effect of diquafosol on tear film parameters and corneal aberrations after cataract surgery. Methods: This retrospective, comparative, observational case series included patients who underwent cataract surgery with or without peri-operative use of diquafosol three per cent ophthalmic solution. Patients in group I (31 eyes) were treated with diquafosol three per cent ophthalmic solution six times a day from one week before surgery to three months after surgery. Patients in group II (33 eyes) underwent cataract surgery without being administered diquafosol. Tear film break-up time (BUT), the ocular surface disease index (OSDI), the Oxford Scheme score, Schirmer's test I and corneal aberrations were determined before and at one and three months post-surgery. Results: In group I, the BUT, OSDI and Oxford Scheme score showed significant improvement at one and three months post-surgery (p = 0.002 for BUT at one month and three months, p = 0.023 and p = 0.049 for OSDI at one month and three months and p = 0.001 and p = 0.026 for Oxford Scheme at one month and three months), compared to baseline. In group II, the BUT, OSDI and Oxford Scheme score did not show any significant improvement during the follow-up period. In both groups, Schirmer's test I significantly decreased at three months post-surgery (p = 0.011 for group I and p = 0.034 for group II), compared to baseline. There were significant differences in the BUT and OSDI between the groups at three months post-surgery (p = 0.037 for BUT and p = 0.011 for OSDI). Regarding the corneal aberration, there were no significant differences between the groups at three months post-surgery. Conclusion: Peri-operative application of diquafosol three per cent ophthalmic solution may prevent dry eye-related ocular surface changes accompanied by improvement of ocular symptom. No definite changes in corneal aberrations were noted.

Original languageEnglish
Pages (from-to)590-594
Number of pages5
JournalClinical and Experimental Optometry
Volume100
Issue number6
DOIs
Publication statusPublished - 2017 Nov 1

Fingerprint

Ophthalmic Solutions
Tears
Cataract
Eye Diseases
diquafosol

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Optometry

Cite this

@article{6c3f228258f445008fd4114423133f8e,
title = "Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery",
abstract = "Background: The aim was to evaluate the effect of diquafosol on tear film parameters and corneal aberrations after cataract surgery. Methods: This retrospective, comparative, observational case series included patients who underwent cataract surgery with or without peri-operative use of diquafosol three per cent ophthalmic solution. Patients in group I (31 eyes) were treated with diquafosol three per cent ophthalmic solution six times a day from one week before surgery to three months after surgery. Patients in group II (33 eyes) underwent cataract surgery without being administered diquafosol. Tear film break-up time (BUT), the ocular surface disease index (OSDI), the Oxford Scheme score, Schirmer's test I and corneal aberrations were determined before and at one and three months post-surgery. Results: In group I, the BUT, OSDI and Oxford Scheme score showed significant improvement at one and three months post-surgery (p = 0.002 for BUT at one month and three months, p = 0.023 and p = 0.049 for OSDI at one month and three months and p = 0.001 and p = 0.026 for Oxford Scheme at one month and three months), compared to baseline. In group II, the BUT, OSDI and Oxford Scheme score did not show any significant improvement during the follow-up period. In both groups, Schirmer's test I significantly decreased at three months post-surgery (p = 0.011 for group I and p = 0.034 for group II), compared to baseline. There were significant differences in the BUT and OSDI between the groups at three months post-surgery (p = 0.037 for BUT and p = 0.011 for OSDI). Regarding the corneal aberration, there were no significant differences between the groups at three months post-surgery. Conclusion: Peri-operative application of diquafosol three per cent ophthalmic solution may prevent dry eye-related ocular surface changes accompanied by improvement of ocular symptom. No definite changes in corneal aberrations were noted.",
author = "Hun Lee and Kim, {Sang Myung} and Seonghee Choi and KyoungYul Seo and Eungkweon Kim and Tae-im Kim",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/cxo.12521",
language = "English",
volume = "100",
pages = "590--594",
journal = "Clinical and Experimental Optometry",
issn = "0816-4622",
publisher = "Wiley-Blackwell",
number = "6",

}

Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery. / Lee, Hun; Kim, Sang Myung; Choi, Seonghee; Seo, KyoungYul; Kim, Eungkweon; Kim, Tae-im.

In: Clinical and Experimental Optometry, Vol. 100, No. 6, 01.11.2017, p. 590-594.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery

AU - Lee, Hun

AU - Kim, Sang Myung

AU - Choi, Seonghee

AU - Seo, KyoungYul

AU - Kim, Eungkweon

AU - Kim, Tae-im

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Background: The aim was to evaluate the effect of diquafosol on tear film parameters and corneal aberrations after cataract surgery. Methods: This retrospective, comparative, observational case series included patients who underwent cataract surgery with or without peri-operative use of diquafosol three per cent ophthalmic solution. Patients in group I (31 eyes) were treated with diquafosol three per cent ophthalmic solution six times a day from one week before surgery to three months after surgery. Patients in group II (33 eyes) underwent cataract surgery without being administered diquafosol. Tear film break-up time (BUT), the ocular surface disease index (OSDI), the Oxford Scheme score, Schirmer's test I and corneal aberrations were determined before and at one and three months post-surgery. Results: In group I, the BUT, OSDI and Oxford Scheme score showed significant improvement at one and three months post-surgery (p = 0.002 for BUT at one month and three months, p = 0.023 and p = 0.049 for OSDI at one month and three months and p = 0.001 and p = 0.026 for Oxford Scheme at one month and three months), compared to baseline. In group II, the BUT, OSDI and Oxford Scheme score did not show any significant improvement during the follow-up period. In both groups, Schirmer's test I significantly decreased at three months post-surgery (p = 0.011 for group I and p = 0.034 for group II), compared to baseline. There were significant differences in the BUT and OSDI between the groups at three months post-surgery (p = 0.037 for BUT and p = 0.011 for OSDI). Regarding the corneal aberration, there were no significant differences between the groups at three months post-surgery. Conclusion: Peri-operative application of diquafosol three per cent ophthalmic solution may prevent dry eye-related ocular surface changes accompanied by improvement of ocular symptom. No definite changes in corneal aberrations were noted.

AB - Background: The aim was to evaluate the effect of diquafosol on tear film parameters and corneal aberrations after cataract surgery. Methods: This retrospective, comparative, observational case series included patients who underwent cataract surgery with or without peri-operative use of diquafosol three per cent ophthalmic solution. Patients in group I (31 eyes) were treated with diquafosol three per cent ophthalmic solution six times a day from one week before surgery to three months after surgery. Patients in group II (33 eyes) underwent cataract surgery without being administered diquafosol. Tear film break-up time (BUT), the ocular surface disease index (OSDI), the Oxford Scheme score, Schirmer's test I and corneal aberrations were determined before and at one and three months post-surgery. Results: In group I, the BUT, OSDI and Oxford Scheme score showed significant improvement at one and three months post-surgery (p = 0.002 for BUT at one month and three months, p = 0.023 and p = 0.049 for OSDI at one month and three months and p = 0.001 and p = 0.026 for Oxford Scheme at one month and three months), compared to baseline. In group II, the BUT, OSDI and Oxford Scheme score did not show any significant improvement during the follow-up period. In both groups, Schirmer's test I significantly decreased at three months post-surgery (p = 0.011 for group I and p = 0.034 for group II), compared to baseline. There were significant differences in the BUT and OSDI between the groups at three months post-surgery (p = 0.037 for BUT and p = 0.011 for OSDI). Regarding the corneal aberration, there were no significant differences between the groups at three months post-surgery. Conclusion: Peri-operative application of diquafosol three per cent ophthalmic solution may prevent dry eye-related ocular surface changes accompanied by improvement of ocular symptom. No definite changes in corneal aberrations were noted.

UR - http://www.scopus.com/inward/record.url?scp=85013460612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013460612&partnerID=8YFLogxK

U2 - 10.1111/cxo.12521

DO - 10.1111/cxo.12521

M3 - Article

VL - 100

SP - 590

EP - 594

JO - Clinical and Experimental Optometry

JF - Clinical and Experimental Optometry

SN - 0816-4622

IS - 6

ER -